Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment

Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment

Stage II colorectal cancer(CRC) patients after surgery alone have a five-year survival rate of ~60-80%; the incremental benefit of adjuvant chemotherapy is

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2023-03, Vol.14, p.1103741-1103741
Hauptverfasser: Wang, Fulong, Lu, Shixun, Zhou, Xin, Di, Xiaotang, Wu, Rujia, Chen, Gong, Tian, Sun
Format: Artikel
Sprache:eng
Schlagworte:
Colorectal Neoplasms - drug therapy
formalin-fixed paraffin-embedded samples (FFPE samples)
Humans
Immunology
Neoplasm Staging
personalized adjuvant drugs
personalized immunotherapy
Precision Medicine
prognosis prediction
Risk Factors
stage II colorectal cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Stage II colorectal cancer(CRC) patients after surgery alone have a five-year survival rate of ~60-80%; the incremental benefit of adjuvant chemotherapy is
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2023.1103741